Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
Works matching IS 20412177 AND DT 2014 AND VI 6 AND IP 1
Results: 39
1
2
Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
3
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
4
Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
5
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
6
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
7
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
8
Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
9
Assessing treatment response to interferon -β : is there a role for MRI?
- Published in:
- 2014
- By:
- Publication type:
- Abstract
10
Vitamin D as an early predictor of multiple sclerosis activity and progression.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
11
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
12
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
13
Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
14
Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
15
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
16
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
17
Upper limb motor reh abilitation impacts white matter microstructure in multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
18
PET imaging of demyelination and remyelination in th ecuprizone mouse model for multiple sclerosis: a comparison between [<sup>11</sup>C]CIC and [<sup>11</sup>C]MeDAS.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
19
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
20
Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
21
Rituximab for relapsing-remitting multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
22
Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
23
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
24
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebocontrolled, Phase 3 trial.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
25
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
26
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
27
Treatment of pediatric multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
28
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a Phase 3b, open-label study.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
29
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
30
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
31
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
32
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
33
MicroRNA-15 5 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
34
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosi.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
35
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
36
Neuroprotection in a novel mouse model of multiple sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
37
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
38
Tobacco Smoking and Multiple Sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2014, v. 6, n. 1, p. 1
- By:
- Publication type:
- Article
39
Foreword.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2014, v. 6, n. 1, p. IV
- Publication type:
- Article